RBOT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RBOT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Vicarious Surgical's Other Net Income (Loss) for the three months ended in Dec. 2023 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.
The historical data trend for Vicarious Surgical's Other Net Income (Loss) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Other Net Income (Loss) | - | - | - | - |
Vicarious Surgical Quarterly Data | ||||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Other Net Income (Loss) | Get a 7-Day Free Trial | - | - | - | - | - |
Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.
Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Vicarious Surgical's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.
William John Kelly | officer: CFO and Treasurer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Adam David Sachs | director, 10 percent owner, officer: President and CEO | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Sammy Khalifa | director, 10 percent owner, officer: Chief Technology Officer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
June Morris | officer: CLO, General Counsel and Sec | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
John Mazzola | officer: Chief Operating Officer | TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810 |
Khosla Ventures Opportunity Associates Ii, Llc | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures V, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures Opportunity Ii, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
David D Ho | director | UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000 |
Philip Liang | director | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Brendel Victoria Carr | director | C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451 |
Beverly A Huss | director | C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
E15 Fund Ii, Lp | other: Sole Shareholder | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Shrikant Patnaik | other: Principal | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Ric Fulop | director | C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803 |
From GuruFocus
By Business Wire Business Wire • 10-13-2022
By GuruFocus Research • 09-08-2023
By Business Wire Business Wire • 02-22-2023
By Business Wire Business Wire • 11-10-2022
By Business Wire Business Wire • 10-24-2022
By Business Wire Business Wire • 11-14-2022
By Business Wire • 07-27-2023
By Business Wire Business Wire • 01-30-2023
By GuruFocus Research GuruFocus Editor • 05-25-2023
By Business Wire Business Wire • 11-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.